Evidence map›Paper›PMID 28112410›Full record

ArticleMedical physics2017

Hybrid ZTE/Dixon MR-based attenuation correction for quantitative uptake estimation of pelvic lesions in PET/MRI.

Andrew P Leynes, Jaewon Yang, Dattesh D Shanbhag, Sandeep S Kaushik, Youngho Seo, Thomas A Hope, Florian Wiesinger, Peder E Z Larson

Abstract read
In one paragraph

Article in Medical physics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 82 citations in OpenAlex.

  1. Journal of pharmaceutical analysis · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology.European journal of nuclear medicine and molecular imaging · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Impact of TOF on Brain PET With Short-LivedFrontiers in medicine · 2022
    Article
  11. Review
  12. Assessing the qualitative and quantitative impacts of simple two-class vs multiple tissue-class MR-based attenuation correction for cardiac PET/MR.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  13. Review
  14. Article
  15. Review
  16. MR-based Attenuation Correction for Brain PET Using 3D Cycle-Consistent Adversarial Network.IEEE transactions on radiation and plasma medical sciences · 2021
    Article
  17. Attenuation correction for human PET/MRI studies.Physics in medicine and biology · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Andrew P LeynesDepartment of Radiology and Biomedical Imaging, University of California San Francisco, 1700 4th St, San Francisco, CA 94158, USA.
Jaewon YangDepartment of Radiology and Biomedical Imaging, University of California San Francisco, 1700 4th St, San Francisco, CA 94158, USA.
Dattesh D ShanbhagGE Global Research, Plot #122, Export Promotion Industrial Park, Phase 2, Hoodi Village, Whitefield Road, Bangalore, 560066, India.
Sandeep S KaushikGE Global Research, Plot #122, Export Promotion Industrial Park, Phase 2, Hoodi Village, Whitefield Road, Bangalore, 560066, India.
Youngho SeoDepartment of Radiology and Biomedical Imaging, University of California San Francisco, 1700 4th St, San Francisco, CA 94158, USA.
Thomas A HopeDepartment of Radiology and Biomedical Imaging, University of California San Francisco, 1700 4th St, San Francisco, CA 94158, USA.
Florian WiesingerGE Global Research, Freisinger Landstrasse 50, 85748 Garching bei München, Germany.
Peder E Z LarsonDepartment of Radiology and Biomedical Imaging, University of California San Francisco, 1700 4th St, San Francisco, CA 94158, USA.
University of California System · USGeneral Electric (India) · INUniversity of California, Berkeley · USUniversity of California, San Francisco · US

Funding

Qualification and Harmonization of PET/MRI for Cancer Clinical TrialsR01CA212148 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HOPE, THOMAS, LAFOREST, RICHARD ANDRE · 2017 to 2022
$2.7M
NCI NIH HHS R01 CA212148
6 · The paper itself

Abstract

purposeThis study introduces a new hybrid ZTE/Dixon MR-based attenuation correction (MRAC) method including bone density estimation for PET/MRI and quantifies the effects of bone attenuation on metastatic lesion uptake in the pelvis.

methodsSix patients with pelvic lesions were scanned using fluorodeoxyglucose (18F-FDG) in an integrated time-of-flight (TOF) PET/MRI system. For PET attenuation correction, MR imaging consisted of two-point Dixon and zero echo-time (ZTE) pulse sequences. A continuous-value fat and water pseudoCT was generated from a two-point Dixon MRI. Bone was segmented from the ZTE images and converted to Hounsfield units (HU) using a continuous two-segment piecewise linear model based on ZTE MRI intensity. The HU values were converted to linear attenuation coefficients (LAC) using a bilinear model. The bone voxels of the Dixon-based pseudoCT were replaced by the ZTE-derived bone to produce the hybrid ZTE/Dixon pseudoCT. The three different AC maps (Dixon, hybrid ZTE/Dixon, CTAC) were used to reconstruct PET images using a TOF-ordered subset expectation maximization algorithm with a point-spread function model. Metastatic lesions were separated into two classes, bone lesions and soft tissue lesions, and analyzed. The MRAC methods were compared using a root-mean-squared error (RMSE), where the registered CTAC was taken as ground truth.

resultsThe RMSE of the maximum standardized uptake values (SUV

conclusionA hybrid ZTE/Dixon MRAC method was developed and applied to pelvic regions in an integrated TOF PET/MRI, demonstrating improved MRAC. This new method included bone density estimation, through which PET quantification is improved.

Indexed as

Bone and BonesBone DensityBone NeoplasmsFemaleFluorodeoxyglucose F18HumansImaging, Three-DimensionalLinear ModelsMagnetic Resonance ImagingMaleMiddle AgedMultimodal ImagingPelvic NeoplasmsPositron-Emission TomographyRadiopharmaceuticalsSoft Tissue NeoplasmsFluorodeoxyglucose F18RadiopharmaceuticalsDixon MRIMRACpelvisTOF-PET/MRIzero echo-time (ZTE) MRI

Identifiers

PMID28112410
PMCPMC5877454
OpenAlexW2582833977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.